These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 7195222)
1. [Pharmacokinetics of AR-L 115 BS in the rat (author's transl)]. Busch U Arzneimittelforschung; 1981; 31(1a):204-9. PubMed ID: 7195222 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics of AR-L 115 BS in rabbits and dogs]. Zimmer A; Hammer R Arzneimittelforschung; 1981; 31(1a):212-6. PubMed ID: 7195224 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of blood levels, excretion and metabolite pattern in rats non-pretreated and pretreated with subacute doses of AR-L 115 BS]. Busch U Arzneimittelforschung; 1981; 31(1a):209-12. PubMed ID: 7195223 [TBL] [Abstract][Full Text] [Related]
7. [AR-L 115 BS, comparison of human metabolite pattern and biotransformation with other species]. Roth W; Prox A; Reuter A; Schmid J; Zimmer A; Zipp H Arzneimittelforschung; 1981; 31(1a):232-5. PubMed ID: 7195228 [TBL] [Abstract][Full Text] [Related]
8. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071 [TBL] [Abstract][Full Text] [Related]
9. Metabolic fate of the new cardiotonic denopamine in animals. 1st communication: absorption, distribution and excretion in the rat, rabbit and dog. Naito K; Furuuchi S; Yamada Y; Otsuka M; Harigaya S Arzneimittelforschung; 1986 Apr; 36(4):643-51. PubMed ID: 3718588 [TBL] [Abstract][Full Text] [Related]
10. [Animal studies on the tolerability of AR-L 115 BS (author's transl)]. Schneider P; Bauer M; Eckenfels A; Lehmann H; Lützen L; Ueberberg H Arzneimittelforschung; 1981; 31(1a):226-32. PubMed ID: 7195227 [TBL] [Abstract][Full Text] [Related]
11. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
12. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics and metabolite pattern of clenbuterol in the rat]. Kopitar Z; Zimmer A Arzneimittelforschung; 1976; 26(7a):1435-41. PubMed ID: 1036935 [TBL] [Abstract][Full Text] [Related]
14. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration. Okuyama Y; Momota K; Morino A Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546 [TBL] [Abstract][Full Text] [Related]
16. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat. Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875 [TBL] [Abstract][Full Text] [Related]
17. Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS. Diederen W; Kadatz R Arzneimittelforschung; 1981; 31(1a):141-6. PubMed ID: 7195207 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of amezinium in rat and dog. Traut M; Brode E; Neumann B; Kummer H Arzneimittelforschung; 1981; 31(9a):1594-604. PubMed ID: 7197974 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats. Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879 [TBL] [Abstract][Full Text] [Related]
20. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse. Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]